Microsoft is to buy Sentillion, a specialist in single sign-on technology for the healthcare industry.
The acquisition represents the latest step in the firm’s growing presence in the health IT market, further extending the capabilities of its Amalga product suite. Microsoft hopes to combine Sentillion’s technologies with its own Amalga Unified Intelligence System (UIS).
The technology giant says integrating the technology into Amalga UIS should make it easier for healthcare professionals to deliver better patient care by streamlining access to multiple IT applications and patient data. In June, Sentillion’s single sign-on technology was licensed by Microsoft for use in Amalga UIS.
Sentillion’s software integrates access to a variety of health care applications, removing many of the barriers of users having to connect and log-in to multiple systems.
Sentillion counts more than 1,000 hospitals among its customers. This includes a strong presence in the UK where clients include Great Ormond Street, Portsmouth, Chelsea and Westminster, Royal National Orthopaedic and Imperial College.
By combining Sentillion’s context management and single sign-on technologies with Amalga UIS, a real-time data aggregation solution, Microsoft aims to give clinicians new insight about patients in real time and enable them to perform the tasks far more quickly.
Sentillion will continue to sell and support its products to new and existing customers while Microsoft invests in the long-term evolution of the combined portfolio of Sentillion and Microsoft health solutions.